The global Hormone Patch market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Contraceptive Patch Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hormone Patch include Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Hormone Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormone Patch. This report contains market size and forecasts of Hormone Patch in global, including the following market information:
Global Hormone Patch Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hormone Patch Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hormone Patch companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hormone Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hormone Patch Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hormone Patch Market Segment Percentages, by Type, 2022 (%)
Contraceptive Patch
Estradiol Patch
Others
Global Hormone Patch Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hormone Patch Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Hormone Patch Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hormone Patch Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hormone Patch revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hormone Patch revenues share in global market, 2022 (%)
Key companies Hormone Patch sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hormone Patch sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Pharmaceuticals Inc.(Viatris)
Twirla
Novartis(HEXAL AG)
Bayer Healthcare Pharmaceuticals
Noven
AbbVie
Hisamitsu Pharmaceutical Co., Inc.
Watson Pharmaceuticals
Johnson & Johnson
ANI Pharmaceuticals
Zhejiang Yatai Pharmaceutical Company Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hormone Patch, market overview.
Chapter 2: Global Hormone Patch market size in revenue and volume.
Chapter 3: Detailed analysis of Hormone Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hormone Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hormone Patch capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hormone Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hormone Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hormone Patch Overall Market Size
2.1 Global Hormone Patch Market Size: 2022 VS 2029
2.2 Global Hormone Patch Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hormone Patch Sales: 2018-2029
3 Company Landscape
3.1 Top Hormone Patch Players in Global Market
3.2 Top Global Hormone Patch Companies Ranked by Revenue
3.3 Global Hormone Patch Revenue by Companies
3.4 Global Hormone Patch Sales by Companies
3.5 Global Hormone Patch Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hormone Patch Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hormone Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hormone Patch Players in Global Market
3.8.1 List of Global Tier 1 Hormone Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Hormone Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hormone Patch Market Size Markets, 2022 & 2029
4.1.2 Contraceptive Patch
4.1.3 Estradiol Patch
4.1.4 Others
4.2 By Type - Global Hormone Patch Revenue & Forecasts
4.2.1 By Type - Global Hormone Patch Revenue, 2018-2023
4.2.2 By Type - Global Hormone Patch Revenue, 2024-2029
4.2.3 By Type - Global Hormone Patch Revenue Market Share, 2018-2029
4.3 By Type - Global Hormone Patch Sales & Forecasts
4.3.1 By Type - Global Hormone Patch Sales, 2018-2023
4.3.2 By Type - Global Hormone Patch Sales, 2024-2029
4.3.3 By Type - Global Hormone Patch Sales Market Share, 2018-2029
4.4 By Type - Global Hormone Patch Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hormone Patch Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Hormone Patch Revenue & Forecasts
5.2.1 By Application - Global Hormone Patch Revenue, 2018-2023
5.2.2 By Application - Global Hormone Patch Revenue, 2024-2029
5.2.3 By Application - Global Hormone Patch Revenue Market Share, 2018-2029
5.3 By Application - Global Hormone Patch Sales & Forecasts
5.3.1 By Application - Global Hormone Patch Sales, 2018-2023
5.3.2 By Application - Global Hormone Patch Sales, 2024-2029
5.3.3 By Application - Global Hormone Patch Sales Market Share, 2018-2029
5.4 By Application - Global Hormone Patch Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Hormone Patch Market Size, 2022 & 2029
6.2 By Region - Global Hormone Patch Revenue & Forecasts
6.2.1 By Region - Global Hormone Patch Revenue, 2018-2023
6.2.2 By Region - Global Hormone Patch Revenue, 2024-2029
6.2.3 By Region - Global Hormone Patch Revenue Market Share, 2018-2029
6.3 By Region - Global Hormone Patch Sales & Forecasts
6.3.1 By Region - Global Hormone Patch Sales, 2018-2023
6.3.2 By Region - Global Hormone Patch Sales, 2024-2029
6.3.3 By Region - Global Hormone Patch Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Hormone Patch Revenue, 2018-2029
6.4.2 By Country - North America Hormone Patch Sales, 2018-2029
6.4.3 US Hormone Patch Market Size, 2018-2029
6.4.4 Canada Hormone Patch Market Size, 2018-2029
6.4.5 Mexico Hormone Patch Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Hormone Patch Revenue, 2018-2029
6.5.2 By Country - Europe Hormone Patch Sales, 2018-2029
6.5.3 Germany Hormone Patch Market Size, 2018-2029
6.5.4 France Hormone Patch Market Size, 2018-2029
6.5.5 U.K. Hormone Patch Market Size, 2018-2029
6.5.6 Italy Hormone Patch Market Size, 2018-2029
6.5.7 Russia Hormone Patch Market Size, 2018-2029
6.5.8 Nordic Countries Hormone Patch Market Size, 2018-2029
6.5.9 Benelux Hormone Patch Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Hormone Patch Revenue, 2018-2029
6.6.2 By Region - Asia Hormone Patch Sales, 2018-2029
6.6.3 China Hormone Patch Market Size, 2018-2029
6.6.4 Japan Hormone Patch Market Size, 2018-2029
6.6.5 South Korea Hormone Patch Market Size, 2018-2029
6.6.6 Southeast Asia Hormone Patch Market Size, 2018-2029
6.6.7 India Hormone Patch Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Hormone Patch Revenue, 2018-2029
6.7.2 By Country - South America Hormone Patch Sales, 2018-2029
6.7.3 Brazil Hormone Patch Market Size, 2018-2029
6.7.4 Argentina Hormone Patch Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hormone Patch Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Hormone Patch Sales, 2018-2029
6.8.3 Turkey Hormone Patch Market Size, 2018-2029
6.8.4 Israel Hormone Patch Market Size, 2018-2029
6.8.5 Saudi Arabia Hormone Patch Market Size, 2018-2029
6.8.6 UAE Hormone Patch Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan Pharmaceuticals Inc.(Viatris)
7.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Summary
7.1.2 Mylan Pharmaceuticals Inc.(Viatris) Business Overview
7.1.3 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Major Product Offerings
7.1.4 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Pharmaceuticals Inc.(Viatris) Key News & Latest Developments
7.2 Twirla
7.2.1 Twirla Company Summary
7.2.2 Twirla Business Overview
7.2.3 Twirla Hormone Patch Major Product Offerings
7.2.4 Twirla Hormone Patch Sales and Revenue in Global (2018-2023)
7.2.5 Twirla Key News & Latest Developments
7.3 Novartis(HEXAL AG)
7.3.1 Novartis(HEXAL AG) Company Summary
7.3.2 Novartis(HEXAL AG) Business Overview
7.3.3 Novartis(HEXAL AG) Hormone Patch Major Product Offerings
7.3.4 Novartis(HEXAL AG) Hormone Patch Sales and Revenue in Global (2018-2023)
7.3.5 Novartis(HEXAL AG) Key News & Latest Developments
7.4 Bayer Healthcare Pharmaceuticals
7.4.1 Bayer Healthcare Pharmaceuticals Company Summary
7.4.2 Bayer Healthcare Pharmaceuticals Business Overview
7.4.3 Bayer Healthcare Pharmaceuticals Hormone Patch Major Product Offerings
7.4.4 Bayer Healthcare Pharmaceuticals Hormone Patch Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Healthcare Pharmaceuticals Key News & Latest Developments
7.5 Noven
7.5.1 Noven Company Summary
7.5.2 Noven Business Overview
7.5.3 Noven Hormone Patch Major Product Offerings
7.5.4 Noven Hormone Patch Sales and Revenue in Global (2018-2023)
7.5.5 Noven Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Hormone Patch Major Product Offerings
7.6.4 AbbVie Hormone Patch Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Hisamitsu Pharmaceutical Co., Inc.
7.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Summary
7.7.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
7.7.3 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Major Product Offerings
7.7.4 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales and Revenue in Global (2018-2023)
7.7.5 Hisamitsu Pharmaceutical Co., Inc. Key News & Latest Developments
7.8 Watson Pharmaceuticals
7.8.1 Watson Pharmaceuticals Company Summary
7.8.2 Watson Pharmaceuticals Business Overview
7.8.3 Watson Pharmaceuticals Hormone Patch Major Product Offerings
7.8.4 Watson Pharmaceuticals Hormone Patch Sales and Revenue in Global (2018-2023)
7.8.5 Watson Pharmaceuticals Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Hormone Patch Major Product Offerings
7.9.4 Johnson & Johnson Hormone Patch Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 ANI Pharmaceuticals
7.10.1 ANI Pharmaceuticals Company Summary
7.10.2 ANI Pharmaceuticals Business Overview
7.10.3 ANI Pharmaceuticals Hormone Patch Major Product Offerings
7.10.4 ANI Pharmaceuticals Hormone Patch Sales and Revenue in Global (2018-2023)
7.10.5 ANI Pharmaceuticals Key News & Latest Developments
7.11 Zhejiang Yatai Pharmaceutical Company Ltd.
7.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Summary
7.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Business Overview
7.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Major Product Offerings
7.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales and Revenue in Global (2018-2023)
7.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Key News & Latest Developments
8 Global Hormone Patch Production Capacity, Analysis
8.1 Global Hormone Patch Production Capacity, 2018-2029
8.2 Hormone Patch Production Capacity of Key Manufacturers in Global Market
8.3 Global Hormone Patch Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hormone Patch Supply Chain Analysis
10.1 Hormone Patch Industry Value Chain
10.2 Hormone Patch Upstream Market
10.3 Hormone Patch Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hormone Patch Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report